Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fréderique de Graaf

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cell Reports Methods|October 26, 2023
Immunophenotyping beyond the limits of timeJ Fréderique de Graaf, Ramon Arens
STAR Protocols|April 23, 2026
Protocol for metabolic profiling of antigen-specific CD8<sup>+</sup> T cells using spectral flow cytometryJ Fréderique de Graaf, Nils Mülling, Ramon Arens
Plos One|March 29, 2021
Identification of a novel conserved signaling motif in CD200 receptor required for its inhibitory functionLaura M Timmerman, J Fréderique de Graaf, Nikolaos Satravelas, et al.
Cell Reports Methods|September 27, 2025
Metabolic profiling of antigen-specific CD8<sup>+</sup> T cells by spectral flow cytometryNils Mülling, J Fréderique de Graaf, Graham A Heieis, et al.
Molecular Therapy. Oncology|January 13, 2025
Cell-derived Newcastle disease virus variant with two amino acid substitutions near cleavage site of F shows favorable traits as oncolytic virusMarco Huberts, J Fréderique de Graaf, Daphne Groeneveld, et al.
Plos One|February 9, 2022
Optimizing environmental safety and cell-killing potential of oncolytic Newcastle Disease virus with modifications of the V, F and HN genesJ Fréderique de Graaf, Stefan van Nieuwkoop, Theo Bestebroer, et al.
Heliyon|July 25, 2022
Comparison between intratumoral and intravenously administered oncolytic virus therapy with Newcastle disease virus in a xenograft murine model for pancreatic adenocarcinomaJ Fréderique de Graaf, Marco Huberts, Daphne Groeneveld, et al.
Journal for Immunotherapy of Cancer|November 29, 2023
Delayed vaccine-induced CD8<sup>+</sup> T cell expansion by topoisomerase I inhibition mediates enhanced CD70-dependent tumor eradicationTetje C van der Sluis, Floortje J van Haften, Suzanne van Duikeren, et al.
The Journal of Clinical Investigation|July 2, 2024
Inhibiting the NADase CD38 improves cytomegalovirus-specific CD8+ T cell functionality and metabolismNils Mülling, Felix M Behr, Graham A Heieis, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cell Reports Methods|October 26, 2023
Immunophenotyping beyond the limits of timeJ Fréderique de Graaf, Ramon Arens
STAR Protocols|April 23, 2026
Protocol for metabolic profiling of antigen-specific CD8<sup>+</sup> T cells using spectral flow cytometryJ Fréderique de Graaf, Nils Mülling, Ramon Arens
Plos One|March 29, 2021
Identification of a novel conserved signaling motif in CD200 receptor required for its inhibitory functionLaura M Timmerman, J Fréderique de Graaf, Nikolaos Satravelas, et al.
Cell Reports Methods|September 27, 2025
Metabolic profiling of antigen-specific CD8<sup>+</sup> T cells by spectral flow cytometryNils Mülling, J Fréderique de Graaf, Graham A Heieis, et al.
Molecular Therapy. Oncology|January 13, 2025
Cell-derived Newcastle disease virus variant with two amino acid substitutions near cleavage site of F shows favorable traits as oncolytic virusMarco Huberts, J Fréderique de Graaf, Daphne Groeneveld, et al.
Plos One|February 9, 2022
Optimizing environmental safety and cell-killing potential of oncolytic Newcastle Disease virus with modifications of the V, F and HN genesJ Fréderique de Graaf, Stefan van Nieuwkoop, Theo Bestebroer, et al.
Heliyon|July 25, 2022
Comparison between intratumoral and intravenously administered oncolytic virus therapy with Newcastle disease virus in a xenograft murine model for pancreatic adenocarcinomaJ Fréderique de Graaf, Marco Huberts, Daphne Groeneveld, et al.
Journal for Immunotherapy of Cancer|November 29, 2023
Delayed vaccine-induced CD8<sup>+</sup> T cell expansion by topoisomerase I inhibition mediates enhanced CD70-dependent tumor eradicationTetje C van der Sluis, Floortje J van Haften, Suzanne van Duikeren, et al.
The Journal of Clinical Investigation|July 2, 2024
Inhibiting the NADase CD38 improves cytomegalovirus-specific CD8+ T cell functionality and metabolismNils Mülling, Felix M Behr, Graham A Heieis, et al.
Pageof 1